The COVID-19 pandemic heightened the psychosocial impact of a cancer diagnosis as patients face concerns about the risk of infection and serious disease and uncertainties about the impact on their treatment. We conducted an online survey (n =317) and focus groups (n =19) with patients to examine their experiences with cancer care during the pandemic. Most survey respondents (68%) reported one or more disruptions or delays in care, including appointments switched to telehealth (49%). Patients perceived both benefits (e.g., convenience) and drawbacks (e.g., more impersonal) to telehealth. For many patients, COVID-19-related restrictions on bringing family members to support them during appointments was a major concern and left them feeling alone and vulnerable during treatment. Patients' self-reported coping during the pandemic was positively associated with age, education, and income (P < .05 for each) and better communication with their doctors during telehealth sessions (P < .001). Study findings highlight the importance of patient-centered care and communication to help patients cope with the challenges of the pandemic. Further research is needed to develop guidelines for use of telehealth as part of patient-centered cancer care.
Patients' experiences with cancer care
Impact of the COVID-19 pandemic
Treiman, K., Kranzler, E. C., Moultrie, R., Arena, L., Mack, N., Fortune, E., Garcia, R., & Street, R. L. (2022). Patients' experiences with cancer care: Impact of the COVID-19 pandemic. Journal of Patient Experience, 9, [23743735221092567]. https://doi.org/10.1177/23743735221092567
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Meet the Experts
View All ExpertsRecent Publications
Article
Spatiotemporal trends in three smoothed overdose death rates in US counties, 2012-2020
METHODS REPORT
Improving text classification with Boolean retrieval for rare categories
Article
COVID-19 diagnosis and SARS-CoV-2 strain identification by a rapid, multiplexed, point-of-care antibody microarray
Article